CCL2 and metabolic dysfunction-associated steatohepatitis: We searched open resources to investigate whether the mRNA expression levels of P2YRs and C-C motif chemokine 2 (CCL2), as inflammatory markers, and collagen type I alpha 1 chain (Col1a1), as a fibrosis marker, are altered in NASH patients.